微信小陈
微信小章| 产品名称： | Proteus mirabilis Hauser |
|---|---|
| 商品货号： | TS201800 |
| Strain Designations： | L9 |
| Isolation： | Derived from existing strain |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Antigenic Properties： | L-Phase Variant |
| Product Format： | freeze-dried |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 243: Mycoplasma medium |
| Growth Conditions： | Temperature: 37.0°C Atmosphere: 5% CO2 |
| Name of Depositor： | RG Wittler |
| Chain of Custody： | ATCC < |
| References： | . . Zentralbl. Bakteriol., I Abt., Orig. 167: 345, 1956. Weibull C, Beckman H. Chemical and metabolic properties of various elements found in cultures of a stable Proteus L form. J. Gen. Microbiol. 24: 379-391, 1961. PubMed: 13783768 Weibull C, Lundin BM. Growth of elements of various sizes found in cultures of a stable Proteus L form. J. Gen. Microbiol. 27: 241-248, 1962. PubMed: 14005594 Cohen RL, et al. Modified biochemical tests for characterization of L-phase variants of bacteria. Appl. Microbiol. 16: 1655-1662, 1968. PubMed: 4302280 derived from Proteus mirabilis 9 (ATCC 14273) |